Human_JJ
neutrophil_NN
elastase_NN
proteolytically_RB
activates_VBZ
the_DT
platelet_NN
integrin_NN
alphaIIbbeta3_NN
through_IN
cleavage_NN
of_IN
the_DT
carboxyl_JJ
terminus_NN
of_IN
the_DT
alphaIIb_NN
subunit_NN
heavy_JJ
chain_NN
._.

Involvement_NN
in_IN
the_DT
potentiation_NN
of_IN
platelet_NN
aggregation_NN
._.

Neutrophil_NN
elastase_NN
-LRB-_-LRB-
NE_NN
-RRB-_-RRB-
and_CC
cathepsin_NN
G_NN
are_VBP
two_CD
serine_NN
proteinases_NNS
released_VBN
concomitantly_RB
by_IN
stimulated_VBN
polymorphonuclear_JJ
neutrophils_NNS
._.

We_PRP
previously_RB
demonstrated_VBD
that_IN
while_IN
NE_NN
by_IN
itself_PRP
does_VBZ
not_RB
activate_VB
human_JJ
platelets_NNS
,_,
it_PRP
strongly_RB
enhances_VBZ
the_DT
weak_JJ
aggregation_NN
induced_VBN
by_IN
a_DT
threshold_NN
concentration_NN
of_IN
cathepsin_NN
G_NN
-LRB-_-LRB-
threshold_NN
of_IN
cathepsin_NN
G_NN
-RRB-_-RRB-
-LRB-_-LRB-
Renesto_NNP
,_,
P._NNP
,_,
and_CC
Chignard_NNP
,_,
M._NNP
-LRB-_-LRB-
1993_CD
-RRB-_-RRB-
Blood_NNP
82_CD
,_,
139-144_CD
-RRB-_-RRB-
._.

The_DT
aim_NN
of_IN
this_DT
study_NN
was_VBD
to_TO
delineate_VB
the_DT
molecular_JJ
mechanisms_NNS
involved_VBN
in_IN
this_DT
potentiation_NN
process_NN
._.

Two_CD
main_JJ
pieces_NNS
of_IN
data_NNS
prompted_VBD
us_PRP
to_TO
focus_VB
on_IN
the_DT
activation_NN
of_IN
the_DT
platelet_NN
fibrinogen_NN
receptor_NN
,_,
the_DT
alphaIIbbeta3_NN
integrin_NN
._.

First_RB
,_,
previous_JJ
studies_NNS
have_VBP
shown_VBN
this_DT
integrin_NN
to_TO
be_VB
particularly_RB
prone_JJ
to_TO
proteolytic_JJ
regulation_NN
of_IN
its_PRP$
function_NN
._.

Second_RB
,_,
we_PRP
found_VBD
that_IN
the_DT
potentiating_NN
activity_NN
of_IN
NE_NN
on_IN
the_DT
threshold_NN
of_IN
cathepsin_NN
G-induced_JJ
platelet_NN
aggregation_NN
was_VBD
strictly_RB
dependent_JJ
on_IN
the_DT
presence_NN
of_IN
exogenous_JJ
fibrinogen_NN
._.

Using_VBG
flow_NN
cytometry_NN
analysis_NN
,_,
NE_NN
was_VBD
shown_VBN
to_TO
trigger_VB
a_DT
time-dependent_JJ
binding_NN
of_IN
PAC-1_NN
and_CC
AP-5_NN
,_,
two_CD
monoclonal_JJ
antibodies_NNS
specific_JJ
for_IN
the_DT
activated_JJ
and_CC
ligand-occupied_JJ
conformers_NNS
of_IN
alphaIIbbeta3_NN
._.

Furthermore_RB
,_,
the_DT
potentiated_JJ
aggregation_NN
was_VBD
shown_VBN
to_TO
result_VB
from_IN
an_DT
increased_VBN
capacity_NN
of_IN
platelets_NNS
to_TO
bind_VB
fibrinogen_NN
._.

Indeed_RB
,_,
the_DT
combination_NN
of_IN
NE_NN
and_CC
threshold_NN
of_IN
cathepsin_NN
G_NN
increased_VBD
the_DT
binding_NN
of_IN
PAC-1_VBG
approximately_RB
5.5-fold_RB
over_IN
basal_JJ
values_NNS
measured_VBN
on_IN
nontreated_JJ
platelets_NNS
,_,
whereas_IN
this_DT
binding_NN
raised_VBD
only_RB
by_IN
approximately_RB
3-fold_RB
in_IN
threshold_NN
of_IN
cathepsin_NN
G-stimulated_JJ
platelets_NNS
-LRB-_-LRB-
p_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
._.

By_IN
contrast_NN
,_,
phosphatidic_JJ
acid_NN
accumulation_NN
,_,
pleckstrin_NN
phosphorylation_NN
,_,
and_CC
calcium_NN
mobilization_NN
produced_VBN
by_IN
the_DT
combination_NN
of_IN
NE_NN
and_CC
threshold_NN
of_IN
cathepsin_NN
G_NN
were_VBD
not_RB
significantly_RB
different_JJ
from_IN
those_DT
measured_VBN
with_IN
threshold_NN
of_IN
cathepsin_NN
G_NN
alone_RB
-LRB-_-LRB-
p_NN
&gt;_JJR
0.05_CD
-RRB-_-RRB-
,_,
indicating_VBG
that_IN
the_DT
phospholipase_NN
C\/protein_NN
kinase_NN
C_NN
pathway_NN
is_VBZ
not_RB
involved_VBN
in_IN
the_DT
potentiation_NN
of_IN
aggregation_NN
._.

The_DT
foregoing_JJ
data_NNS
,_,
as_RB
well_RB
as_IN
the_DT
requirement_NN
of_IN
catalytically_RB
active_JJ
NE_NNS
to_TO
trigger_VB
alphaIIbbeta3_NN
activation_NN
and_CC
potentiate_VB
threshold_NN
of_IN
cathepsin_NN
G-initiated_JJ
platelet_NN
aggregation_NN
,_,
led_VBD
us_PRP
to_TO
examine_VB
whether_IN
the_DT
structure_NN
of_IN
this_DT
integrin_NN
was_VBD
affected_VBN
by_IN
NE_NN
._.

Immunoblot_NN
and_CC
flow_NN
cytometry_NN
analysis_NN
revealed_VBD
a_DT
limited_JJ
proteolysis_NN
of_IN
the_DT
carboxyl_NN
terminus_NN
of_IN
the_DT
alphaIIb_NN
subunit_NN
heavy_JJ
chain_NN
-LRB-_-LRB-
alphaIIbH_NN
-RRB-_-RRB-
,_,
as_IN
judged_VBN
by_IN
the_DT
disappearance_NN
of_IN
the_DT
epitope_NN
for_IN
the_DT
monoclonal_JJ
antibody_NN
PMI-1_NN
._.

Mass_JJ
spectrometry_NN
studies_NNS
performed_VBN
on_IN
a_DT
synthetic_JJ
peptide_NN
mapping_VBG
over_IN
the_DT
cleavage_NN
domain_NN
of_IN
alphaIIbH_NN
predicted_VBD
the_DT
site_NN
of_IN
proteolysis_NN
as_IN
located_JJ
between_IN
Val837_NN
and_CC
Asp838_NN
._.

Treatment_NN
by_IN
NE_NN
of_IN
ATP-depleted_JJ
platelets_NNS
or_CC
Chinese_JJ
hamster_NN
ovary_NN
cells_NNS
expressing_VBG
human_JJ
recombinant_JJ
alphaIIbbeta3_NN
clearly_RB
established_VBD
that_IN
activation_NN
of_IN
the_DT
integrin_NN
was_VBD
independent_JJ
of_IN
signal_NN
transduction_NN
events_NNS
and_CC
was_VBD
concomitant_JJ
with_IN
the_DT
proteolysis_NN
of_IN
alphaIIbH_NN
._.

